SCHEMBL7010709

SCHEMBL7010709

CCc1c[c]nc(-c2ccc(C)cc2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 1/20 0.35
SREBF2 Q12772 1/20 0.35
HEXA P06865 1/20 0.35
HEXB P07686 1/20 0.35
TDP1 Q9NUW8 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 2/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NPC1 O15118 6/20 0.33
RAB9A P51151 6/20 0.33
MAPT P10636 2/20 0.33
CASP3 P42574 2/20 0.33
SENP8 Q96LD8 2/20 0.33
SENP7 Q9BQF6 2/20 0.33
SENP6 Q9GZR1 2/20 0.33
LMNA P02545 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015292 0.85 CYP1A2 (0.40) HEXAHEXBTDP1MAPK1TSHR
SCHEMBL2374294 0.71
SCHEMBL25813893 0.66 TP53 (0.48) HEXAHEXBL3MBTL1SMN1; SMN2NPC1
SCHEMBL15131515 0.66 ADORA3 (0.41) HEXAHEXBL3MBTL1MAPK1NPSR1
SCHEMBL12621115 0.66 TP53 (0.48) HEXAHEXBL3MBTL1SMN1; SMN2NPC1
SCHEMBL6111135 0.65 L3MBTL1 (0.52) TDP1L3MBTL1NPSR1NPC1RAB9A
SCHEMBL11810896 0.65 L3MBTL1 (0.52) TDP1L3MBTL1NPSR1NPC1RAB9A
SCHEMBL12622359 0.64 TP53 (0.47) HEXAHEXBL3MBTL1SMN1; SMN2NPC1
SCHEMBL15131512 0.64 ADORA3 (0.41) HEXAHEXBL3MBTL1MAPK1NPC1
SCHEMBL13064199 0.64 SREBF2 (0.47) SREBF1SREBF2TDP1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318814-A2 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-06-18 EP disclosed
EP-1317452-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-06-11 EP disclosed
EP-1317449-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-06-11 EP disclosed
EP-1317450-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-06-11 EP disclosed
EP-1317448-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2003-06-11 EP disclosed
WO-2002022604-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-03-21 WO disclosed
WO-2002022608-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-03-21 WO disclosed
WO-2002022602-A2 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-03-21 WO disclosed
WO-2002022605-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-03-21 WO disclosed
WO-2002022606-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-03-21 WO disclosed